drugset / Trial / NCT02690844
Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
RandomizedParallel-groupSingle-blindTreatment
Summary
What affect does the use of a mucoadhesive drug delivery system (Mucolox®) compounded with clonazepam have in the treatment of burning mouth syndrome? There are no clinical trials reported in the literature that evaluate the use of a mucoadhesive vehicle to deliver clonazepam into the oral cavity and treat burning mouth syndrome. The use of a mucoadhesive may help to increase surface contact and elicit a greater reduction in symptoms.
Timeline
- Start
- 2016-04
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonazepam | Small molecule | 1 mg | Other |